How it works
The proposed mechanisms come from rodent work: effects on angiogenesis, on fibroblast migration in tendon and ligament tissue, and on the nitric oxide system. Several of those animal results are consistent across labs.
None of it has been carried into human efficacy trials. An animal mechanism is a reason to run a trial, not a substitute for one, and the distance between the two is where most of the marketing for this compound sits.
What the evidence shows
There are no completed randomised controlled trials of BPC-157 in humans for any indication. This is the single most important fact on this page and it is usually omitted from the pages selling it.
Typical dosing
There is no established human dose, because there is no human trial to establish one from. Protocols circulating online are extrapolated from rodent studies.
Reported side effects
No human safety profile exists. The absence of reported side effects reflects the absence of controlled study, not a demonstrated safety record.
Labelled warnings and contraindications
- No human toxicology, no established dose, no label, and no regulatory review of any kind.
- The FDA placed BPC-157 in Category 2 of its bulk drug substances review in 2023, the category for substances raising significant safety risks. That closed the compounding route.
- Prohibited by the World Anti-Doping Agency under the non-approved substances category. Competing athletes will test positive.
- Product sold as BPC-157 is unregulated. Identity, purity and sterility are not verified by anyone.
Legal status and sourcing
BPC-157 is not approved as a drug anywhere and is not a lawful dietary supplement ingredient. It is sold almost entirely under a research-use-only label, which is a labelling position rather than a quality standard.
The 2023 FDA Category 2 designation means compounding pharmacies cannot lawfully prepare it. Clinics still offering it are operating outside that framework.
What it costs
There is no legitimate commercial route to price. BPC-157 is not an approved medicine and cannot lawfully be compounded, so every figure quoted for it is for unregulated research-use material. We do not publish those prices. Listing them next to pharmacy pricing would imply a comparison that does not exist.
How confident anyone can be
Very low. Not because the animal data is bad, some of it is reasonably consistent, but because nothing has been done to find out whether any of it transfers to people.
Anyone telling you what BPC-157 does in humans, in either direction, is going beyond the evidence. That includes us.